CIK 0001997038
Iambic Therapeutics, Inc.
Sign in to watch- Ticker
- IAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- other
- EIN
- 843364168
- Phone
- (626) 592-2520
- Business address
- 5627 OBERLIN DRIVE, SUITE 120, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $11,500,000
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,500,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-14 | Miller Thomas F. Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +793,200 | 793,200 | ||
| 2026-10-14 | Josephson Neil Chief Medical Officer | Grant or award | +31,000 | 71,459 | ||
| 2026-10-14 | Josephson Neil Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +185,900 | 185,900 | ||
| 2026-10-14 | Secora Michael CFO & Chief Corp Dev Ofcr | Grant or award | +28,400 | 218,560 | ||
| 2026-10-14 | Secora Michael CFO & Chief Corp Dev Ofcr | Grant or award · Employee Stock Option (right to buy) | +170,300 | 170,300 | ||
| 2026-10-14 | Sharp Shalini Director | Grant or award · Stock Option (right to buy) | +20,300 | 20,300 | ||
| 2026-10-14 | TAGLIAFERRI MARY Director | Grant or award · 10/14/2026 | +20,300 | 20,300 | ||
| 2026-10-14 | EMSTER KURT VON Director | Grant or award · Stock Option (right to buy) | +20,300 | 20,300 | ||
| 2026-10-14 | RASTETTER WILLIAM H Director | Grant or award · Stock Option (right to buy) | +40,600 | 40,600 |
Page 3 of 3 · 49 trades